| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.007 |